Revolution Medicines (RVMD) Net Equity Issued and Repurchased (2019 - 2026)
Revolution Medicines' Net Equity Issued and Repurchased was $1.69 billion in Q2 2026, compared with $6.58 million a year earlier.
Powered by 
Analysis
Revolution Medicines (RVMD) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' Net Equity Issued and Repurchased was $1.72 billion through Jun 30, 2026, up 105.2% year-over-year; for FY2025, it came in at $29.17 million, down 96.5% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -41.4% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $840.4 million in FY2024 (+154.4%), $330.34 million in FY2023 (+31.4%), $251.47 million in FY2022 (-11.6%) and $284.51 million in FY2021 (-32.7%).
- The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2019.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in three of the last five quarters, with growth averaging 27.0%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2024 (growth of 196.8%); the worst was Q1 2022 (a decline of 99.9%).
- Per Business Quant data, RVMD's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $12.27 million (Q1 2026), $17.55 million (Q4 2025) and $4.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,214.50 Bn | 1,188.12 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 657.77 Bn | 577.63 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 511.97 Bn | 479.98 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 361.64 Bn | 324.58 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 314.67 Bn | 287.91 Bn | - | - |
| 6 | Astrazeneca | 288.02 Bn | 261.91 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 249.48 Bn | 201.14 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.20 Bn | 183.31 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 166.92 Bn | 114.28 Bn | 12.56 Bn | - |
| 10 | Revolution Medicines | 40.51 Bn | 28.99 Bn | 197.23 Mn | 21.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.33 Mn |
| Jun 30, 2026 | 1.69 Bn |
| Mar 31, 2026 | 12.27 Mn |
| Dec 31, 2025 | 17.55 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Mar 31, 2025 | 892,000.00 |
| Dec 31, 2024 | 829.09 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 810,000.00 |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 248.34 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 305,000.00 |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 319,000.00 |
| Jun 30, 2021 | 868,000.00 |
API Access
Revolution Medicines Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();